Evidence map›Paper›PMID 28881693›Full record

ArticleOncotarget2017

Predictive factors of para-aortic lymph nodes metastasis in cervical cancer patients: a retrospective analysis based on 723 para-aortic lymphadenectomy cases.

Xiaotian Han, Hao Wen, Xingzhu Ju, Xiaojun Chen, Guihao Ke, Yuqi Zhou, Jin Li, Lingfang Xia, Jia Tang, Shanhui Liang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xiaotian Han *Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Hao Wen *Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Xingzhu JuDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Xiaojun ChenDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Guihao KeDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Yuqi ZhouDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Jin LiDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Lingfang XiaDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Jia TangDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Shanhui LiangDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Xiaohua WuDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, PR China.
Shanghai Medical College of Fudan University · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Para-aortic lymph node (PALN) dissection is optional and controversial in patients with stage IB1-IIA2 cervical cancer. This retrospective study investigated PALN involvement patterns and evaluated preoperative clinical factors. A total of 723 consecutive FIGO stage IB1-IIA2 cervical cancer patients were included in the study. All patients underwent radical hysterectomy/radical trachelectomy, pelvic lymph node dissection, and PALN dissection. PALN metastasis was found in 101 (14.0%) patients, and the positive PALN rates of stage IB1, IB2, IIA1, and IIA2 were 8.4%, 11.1%, 17.2% and 21.7%, respectively. A multivariate model suggested age > 46 years (OR: 1.67, 95% confidence interval (CI): 1.08-2.58), tumor size > 3.5 cm (OR: 1.79, 95% CI: 1.12-2.87), and FIGO stage IIA (

Indexed as

cervical cancerlymphadenectomypara-aortic lymph nodepelvic lymph nodeSCCA

Identifiers

PMID28881693
PMCPMC5584294
OpenAlexW2593311415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.